Economic evaluation of a cluster randomized, non-inferiority trial of differentiated service delivery models of HIV treatment in Zimbabwe
About 85% of Zimbabwe’s >1.4 million people living with HIV are on antiretroviral treatment (ART). Further expansion of its treatment program will require more efficient use of existing resources. Two promising strategies for reducing resource utilization per patient are multi-month medication di...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-01-01
|
| Series: | PLOS Global Public Health |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021451/?tool=EBI |
| _version_ | 1797694896867377152 |
|---|---|
| author | Mariet Benade Brooke E. Nichols Geoffrey Fatti Salome Kuchukhidze Kudakwashe Takarinda Nicoletta Mabhena-Ngorima Ashraf Grimwood Sydney Rosen |
| author_facet | Mariet Benade Brooke E. Nichols Geoffrey Fatti Salome Kuchukhidze Kudakwashe Takarinda Nicoletta Mabhena-Ngorima Ashraf Grimwood Sydney Rosen |
| author_sort | Mariet Benade |
| collection | DOAJ |
| description | About 85% of Zimbabwe’s >1.4 million people living with HIV are on antiretroviral treatment (ART). Further expansion of its treatment program will require more efficient use of existing resources. Two promising strategies for reducing resource utilization per patient are multi-month medication dispensing and community-based service delivery. We evaluated the costs to providers and patients of community-based, multi-month ART delivery models in Zimbabwe. We used resource and outcome data from a cluster-randomized non-inferiority trial of three differentiated service delivery (DSD) models targeted to patients stable on ART: 3-month facility-based care (3MF), community ART refill groups (CAGs) with 3-month dispensing (3MC), and CAGs with 6-month dispensing (6MC). Using local unit costs, we estimated the annual cost in 2020 USD of providing HIV treatment per patient from the provider and patient perspectives. In the trial, retention at 12 months was 93.0% in the 3MF, 94.8% in the 3MC, and 95.5% in the 6MC arms. The total average annual cost of HIV treatment per patient was $187 (standard deviation $39), $178 ($30), and $167 ($39) in each of the three arms, respectively. The annual cost/patient was dominated by ART medications (79% in 3MF, 87% in 3MC; 92% in 6MC), followed by facility visits (12%, 5%, 5%, respectively) and viral load (8%, 8%, 2%, respectively). When costs were stratified by district, DSD models cost slightly less, with 6MC the least expensive in all districts. Savings were driven by differences in the number of facility visits made/year, as expected, and low uptake of annual viral load tests in the 6-month arm. The total annual cost to patients to obtain HIV care was $10.03 ($2) in the 3MF arm, $5.12 ($0.41) in the 3MC arm, and $4.40 ($0.39) in the 6MF arm. For stable ART patients in Zimbabwe, 3- and 6-month community-based multi-month dispensing models cost less for both providers and patients than 3-month facility-based care and had non-inferior outcomes. |
| first_indexed | 2024-03-12T03:03:32Z |
| format | Article |
| id | doaj.art-cf4fa124b9ff43b2aa1745496e671598 |
| institution | Directory Open Access Journal |
| issn | 2767-3375 |
| language | English |
| last_indexed | 2024-03-12T03:03:32Z |
| publishDate | 2023-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLOS Global Public Health |
| spelling | doaj.art-cf4fa124b9ff43b2aa1745496e6715982023-09-03T14:34:40ZengPublic Library of Science (PLoS)PLOS Global Public Health2767-33752023-01-0133Economic evaluation of a cluster randomized, non-inferiority trial of differentiated service delivery models of HIV treatment in ZimbabweMariet BenadeBrooke E. NicholsGeoffrey FattiSalome KuchukhidzeKudakwashe TakarindaNicoletta Mabhena-NgorimaAshraf GrimwoodSydney RosenAbout 85% of Zimbabwe’s >1.4 million people living with HIV are on antiretroviral treatment (ART). Further expansion of its treatment program will require more efficient use of existing resources. Two promising strategies for reducing resource utilization per patient are multi-month medication dispensing and community-based service delivery. We evaluated the costs to providers and patients of community-based, multi-month ART delivery models in Zimbabwe. We used resource and outcome data from a cluster-randomized non-inferiority trial of three differentiated service delivery (DSD) models targeted to patients stable on ART: 3-month facility-based care (3MF), community ART refill groups (CAGs) with 3-month dispensing (3MC), and CAGs with 6-month dispensing (6MC). Using local unit costs, we estimated the annual cost in 2020 USD of providing HIV treatment per patient from the provider and patient perspectives. In the trial, retention at 12 months was 93.0% in the 3MF, 94.8% in the 3MC, and 95.5% in the 6MC arms. The total average annual cost of HIV treatment per patient was $187 (standard deviation $39), $178 ($30), and $167 ($39) in each of the three arms, respectively. The annual cost/patient was dominated by ART medications (79% in 3MF, 87% in 3MC; 92% in 6MC), followed by facility visits (12%, 5%, 5%, respectively) and viral load (8%, 8%, 2%, respectively). When costs were stratified by district, DSD models cost slightly less, with 6MC the least expensive in all districts. Savings were driven by differences in the number of facility visits made/year, as expected, and low uptake of annual viral load tests in the 6-month arm. The total annual cost to patients to obtain HIV care was $10.03 ($2) in the 3MF arm, $5.12 ($0.41) in the 3MC arm, and $4.40 ($0.39) in the 6MF arm. For stable ART patients in Zimbabwe, 3- and 6-month community-based multi-month dispensing models cost less for both providers and patients than 3-month facility-based care and had non-inferior outcomes.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021451/?tool=EBI |
| spellingShingle | Mariet Benade Brooke E. Nichols Geoffrey Fatti Salome Kuchukhidze Kudakwashe Takarinda Nicoletta Mabhena-Ngorima Ashraf Grimwood Sydney Rosen Economic evaluation of a cluster randomized, non-inferiority trial of differentiated service delivery models of HIV treatment in Zimbabwe PLOS Global Public Health |
| title | Economic evaluation of a cluster randomized, non-inferiority trial of differentiated service delivery models of HIV treatment in Zimbabwe |
| title_full | Economic evaluation of a cluster randomized, non-inferiority trial of differentiated service delivery models of HIV treatment in Zimbabwe |
| title_fullStr | Economic evaluation of a cluster randomized, non-inferiority trial of differentiated service delivery models of HIV treatment in Zimbabwe |
| title_full_unstemmed | Economic evaluation of a cluster randomized, non-inferiority trial of differentiated service delivery models of HIV treatment in Zimbabwe |
| title_short | Economic evaluation of a cluster randomized, non-inferiority trial of differentiated service delivery models of HIV treatment in Zimbabwe |
| title_sort | economic evaluation of a cluster randomized non inferiority trial of differentiated service delivery models of hiv treatment in zimbabwe |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021451/?tool=EBI |
| work_keys_str_mv | AT marietbenade economicevaluationofaclusterrandomizednoninferioritytrialofdifferentiatedservicedeliverymodelsofhivtreatmentinzimbabwe AT brookeenichols economicevaluationofaclusterrandomizednoninferioritytrialofdifferentiatedservicedeliverymodelsofhivtreatmentinzimbabwe AT geoffreyfatti economicevaluationofaclusterrandomizednoninferioritytrialofdifferentiatedservicedeliverymodelsofhivtreatmentinzimbabwe AT salomekuchukhidze economicevaluationofaclusterrandomizednoninferioritytrialofdifferentiatedservicedeliverymodelsofhivtreatmentinzimbabwe AT kudakwashetakarinda economicevaluationofaclusterrandomizednoninferioritytrialofdifferentiatedservicedeliverymodelsofhivtreatmentinzimbabwe AT nicolettamabhenangorima economicevaluationofaclusterrandomizednoninferioritytrialofdifferentiatedservicedeliverymodelsofhivtreatmentinzimbabwe AT ashrafgrimwood economicevaluationofaclusterrandomizednoninferioritytrialofdifferentiatedservicedeliverymodelsofhivtreatmentinzimbabwe AT sydneyrosen economicevaluationofaclusterrandomizednoninferioritytrialofdifferentiatedservicedeliverymodelsofhivtreatmentinzimbabwe |